Aphria (TSX:APHA): 4 Takeaways From Latest Q3 2020 Earnings

Marijuana firm Aphria’s (TSX:APHA)(NYSE:APHA) stock price surged in early trading on Wednesday. The cause was the release of its latest earnings results for its fiscal third-quarter 2020, which ended in February. Aphria was one of the most closely watched cannabis stocks in April for its potential to deliver strong financial results, and it did just that. Quarterly revenue at $144.4…

Read More

The Cannabis Connection to Coronavirus

That Canadians are stressed shouldn’t come as much of a shock. After all, the COVID-19 crisis has sent stocks plummeting, one in three Canadians worry they won’t make rent or mortgage payments, and thousands of people have lost their jobs. It’s therefore little wonder that some Canadians have turned to cannabis for stress relief. Canadians have flooded online cannabis retail…

Read More

1 Cannabis Stock I’m Buying While It’s Still Cheap

You’ll think I’m crazy, but with markets at lows not seen in years, perhaps the craziness of the market place is getting to me. I’ve been looking hard for cheap stocks to buy up while I can. Whereas before I would have to have a couple thousand dollars stashed away, right now I might need only a couple hundred bucks…

Read More

Why the Cronos Group Stock Price Fell 18.3% in February

The Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) stock price fell 18.3% in February. The market continues to fall and company-specific uncertainty remains high. This is making any prediction for the Cronos Group stock price very uncertain and precarious. Fears of the potential severity of the coronavirus have ruled the market since February. This certainly continues today. As I write this article, I…

Read More

Canopy Growth’s (TSX:WEED) CEO Cracks the Whip: Will the Stock Price Jump?

Canadian marijuana giant Canopy Growth (TSX:WEED)(NYSE:CGC) made the big announcement that it’s shutting down two very large greenhouses and laying off about 500 employees as it undergoes an organizational and strategic review that could positively impact the company’s stock price in the long term. Newly installed CEO David Klein is a strong numbers man. It was only a matter of…

Read More

Why Is Cronos Group (TSX:CRON) Delaying Its Earnings Results?

Cannabis producer and innovation giant Cronos Group (TSX:CRON)(NASDAQ:CRON) announced on Monday that it will delay the release of its fourth quarter and full year 2019 earnings results originally slated for Thursday, February 27 as it has experienced a delay. No reason was given for the earnings release postponement, no new specific date was given for the delayed filings and the…

Read More

Aurora Cannabis (TSX:ACB) Revenue Falls 26%: Time to Sell the Stock?

This past week, Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) released its earnings for the second quarter of 2020, and they were, predictably, bad. The company reported a 26% drop in net revenue along with a colossal $1.3 billion GAAP net loss. While the net loss was mostly due to a goodwill impairment charge, the company also reported a $80 million adjusted EBITDA loss that…

Read More

HEXO (TSX:HEXO) Abruptly Changes Auditors: Should Investors Raise Eyebrows?

HEXO Corp (TSX:HEXO)(NYSE:HEXO) announced on Friday, February 7 that it had changed its auditors effective January 31, 2020, and this could raise some investor concerns, considering the cannabis firm was recently “pressured” to restate its earnings. The company has changed its auditors from MNP LLP to PricewaterhouseCoopers LLP, and there has been no statutorily required reportable events upon the change,…

Read More

Namaste Technologies (TSXV:N) Stock Doubles in 3 Weeks! Is There Further Upside?

Online cannabis retailer Namaste Technologies’s (TSXV:N) stock price has apparently doubled in the first three weeks of 2020 after a strong 23% surge on Wednesday raised the year-to-date return to 106% at end of day. This all happened without any company-specific news on the day. This is a strong recovery since trade in the company’s shares touched a 52-week low…

Read More

Is HEXO Stock a Buy After Restated Earnings?

Cannabis producer HEXO’s (TSX:HEXO)(NYSE:HEXO) stock has been on a strong rebound lately since the start of the new year and the share price closed nearly 16% higher on Wednesday as the pot industry received an Organigram Holdings powered valuation boost. The company recently filed restated financial reports for its fiscal year which ended July 31, 2019 as well as amended…

Read More